Cite
Fukunaga T, Tamada T, Kanomata N, et al. Quantitative diffusion-weighted imaging and dynamic contrast-enhanced MR imaging for assessment of tumor aggressiveness in prostate cancer at 3T. Magn Reson Imaging. 2021;83:152-159doi: 10.1016/j.mri.2021.08.009.
Fukunaga, T., Tamada, T., Kanomata, N., Takeuchi, M., Ueda, Y., Miyaji, Y., Kido, A., Yamamoto, A., & Sone, T. (2021). Quantitative diffusion-weighted imaging and dynamic contrast-enhanced MR imaging for assessment of tumor aggressiveness in prostate cancer at 3T. Magnetic resonance imaging, 83152-159. https://doi.org/10.1016/j.mri.2021.08.009
Fukunaga, Takeshi, et al. "Quantitative diffusion-weighted imaging and dynamic contrast-enhanced MR imaging for assessment of tumor aggressiveness in prostate cancer at 3T." Magnetic resonance imaging vol. 83 (2021): 152-159. doi: https://doi.org/10.1016/j.mri.2021.08.009
Fukunaga T, Tamada T, Kanomata N, Takeuchi M, Ueda Y, Miyaji Y, Kido A, Yamamoto A, Sone T. Quantitative diffusion-weighted imaging and dynamic contrast-enhanced MR imaging for assessment of tumor aggressiveness in prostate cancer at 3T. Magn Reson Imaging. 2021 Nov;83:152-159. doi: 10.1016/j.mri.2021.08.009. Epub 2021 Aug 25. PMID: 34454006.
Copy
Download .nbib